Back
Myriad Genetics, Inc. Stock Predictions
Meet America's Newest $1B Unicorn
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
Sell
36
MYGN
Myriad Genetics, Inc.
Last Price:
$6.58
Seasonality Move:
2.22%
7 Day Trial
ALL ACCESS PASS
$
7
Exxon and Chevron Have an Unlikely New Competitor
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available atMyriad Genetics, Inc. Stock Forecast
-
Over the next 52 weeks, Myriad Genetics, Inc. has on average historically risen by 20.4% based on the past 30 years of stock performance.
-
Myriad Genetics, Inc. has risen higher in 12 of those 30 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
-
Is Myriad Genetics, Inc. Stock Undervalued?The current Myriad Genetics, Inc. [MYGN] share price is $6.58. The Score for MYGN is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
-
MYGN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Myriad Genetics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Myriad Genetics, Inc. has on average historically risen by 20.4% based on the past 30 years of stock performance.
Myriad Genetics, Inc. Stock Rating
Sell
36
Myriad Genetics, Inc. (MYGN)
is a Sell
Is Myriad Genetics, Inc. overpriced?
-
Myriad Genetics, Inc. has risen higher in 12 of those 30 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
Myriad Genetics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
myriad.com
52-Week Data
52-Week High:
15.47
52-Week Low:
3.76
Prediction Charts
Market Cap:
613.3M
Price in USD:
6.58
Volume:
849.8K
Beta:
1.11
Technical Analysis
SMA50:
6.94
SMA100:
7.09
SMA200:
6.44
52-Wk Change:
-55.48%
Stock Predictions
-
Is Myriad Genetics, Inc. stock public?Yes, Myriad Genetics, Inc. is a publicly traded company.
-
What is the Myriad Genetics, Inc. stock quote today?The Myriad Genetics, Inc. stock price is 6.58 USD today.
-
How to buy Myriad Genetics, Inc. stock online?You can buy Myriad Genetics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-18 | 7.03 | 6.70 | 7.20 | 6.62 |
| Dec-19 | 6.68 | 6.55 | 6.74 | 6.53 |
| Dec-22 | 6.58 | 6.76 | 6.89 | 6.51 |
| Dec-23 | 6.73 | 6.56 | 6.77 | 6.54 |
| Dec-24 | 6.51 | 6.55 | 6.56 | 6.38 |
| Dec-26 | 6.48 | 6.48 | 6.62 | 6.39 |
| Dec-29 | 6.57 | 6.31 | 6.57 | 6.29 |
| Dec-30 | 6.30 | 6.17 | 6.30 | 6.15 |
| Dec-31 | 6.14 | 6.15 | 6.20 | 6.10 |
| Jan-5 | 6.15 | 6.14 | 6.23 | 6.09 |
| Jan-6 | 6.13 | 6.52 | 6.55 | 6.10 |
| Jan-7 | 6.52 | 6.63 | 6.85 | 6.50 |
| Jan-8 | 6.44 | 6.56 | 6.66 | 6.44 |
| Jan-9 | 6.64 | 6.58 | 6.71 | 6.40 |
Myriad Genetics, Inc. Earnings
Myriad Genetics, Inc. Earnings Report: Per Share Myriad Genetics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Myriad Genetics, Inc. Forecast Revenue Growth
Myriad Genetics, Inc. Stock Analysis: Historical quarterly revenues per share for Myriad Genetics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.07 per share, and an increase next year of $0.08 per share.
* Myriad Genetics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.